BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17658628)

  • 21. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.
    Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D
    Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome.
    Santaella ML; Font I; Disdier OM
    P R Health Sci J; 2004 Jun; 23(2):89-93. PubMed ID: 15377055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A controlled randomized trial of the use of combined L-carnitine and acetyl-L-carnitine treatment in men with oligoasthenozoospermia].
    Li Z; Chen GW; Shang XJ; Bai WJ; Han YF; Chen B; Teng XM; Meng FH; Zhang B; Chen DN; Liu JH; Zheng XM; Cao XR; Liu Y; Zhu XB; Wang YX
    Zhonghua Nan Ke Xue; 2005 Oct; 11(10):761-4. PubMed ID: 16281510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaco-electroencephalographic and clinical effects of the cholinergic substance--acetyl-L-carnitine--in patients with organic brain syndrome.
    Herrmann WM; Dietrich B; Hiersemenzel R
    Int J Clin Pharmacol Res; 1990; 10(1-2):81-4. PubMed ID: 2201660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acetyl-L-carnitine oral administration on lymphocyte antibacterial activity and TNF-alpha levels in patients with active pulmonary tuberculosis. A randomized double blind versus placebo study.
    Jirillo E; Altamura M; Munno I; Pellegrino NM; Sabato R; Di Fabio S; De Simone C
    Immunopharmacol Immunotoxicol; 1991; 13(1-2):135-46. PubMed ID: 1770216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of acetyl-L-carnitine in the treatment of painful peripheral neuropathies in HIV+ patients.
    Scarpini E; Sacilotto G; Baron P; Cusini M; Scarlato G
    J Peripher Nerv Syst; 1997; 2(3):250-2. PubMed ID: 10975731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological performance in persons with chronic fatigue syndrome: results from a population-based study.
    Majer M; Welberg LA; Capuron L; Miller AH; Pagnoni G; Reeves WC
    Psychosom Med; 2008 Sep; 70(7):829-36. PubMed ID: 18606722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain.
    Bonavita E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The feeling of fatigue--fatigue severity by unidimensional versus composite questionnaires.
    Naschitz JE; Rozenbaum M; Shaviv N; Fields MC; Enis S; Babich JP; Manor H; Yeshurun D; Sabo E; Rosner I
    Behav Med; 2004; 29(4):167-72. PubMed ID: 15369197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
    Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
    Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue.
    Olsson EM; von Schéele B; Panossian AG
    Planta Med; 2009 Feb; 75(2):105-12. PubMed ID: 19016404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chinese herbal medicine for Mild Cognitive Impairment and Age Associated Memory Impairment: a review of randomised controlled trials.
    May BH; Yang AW; Zhang AL; Owens MD; Bennett L; Head R; Cobiac L; Li CG; Hugel H; Story DF; Xue CC
    Biogerontology; 2009 Apr; 10(2):109-23. PubMed ID: 18716893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD; Shults J; Rutherford N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artificial disc versus fusion: a prospective, randomized study with 2-year follow-up on 99 patients.
    Sasso RC; Smucker JD; Hacker RJ; Heller JG
    Spine (Phila Pa 1976); 2007 Dec; 32(26):2933-40; discussion 2941-2. PubMed ID: 18091483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fatigue in elderly patients on dialysis].
    Lobbedez T; Desbordes E; Joly F; Ficheux M; Henri P; Ryckelynck JP
    Nephrol Ther; 2008 Dec; 4(7):584-9. PubMed ID: 18672416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting.
    Wattmo C; Hansson O; Wallin AK; Londos E; Minthon L
    Dement Geriatr Cogn Disord; 2008; 26(3):203-11. PubMed ID: 18769065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.